08.03.2022 • NewsAceto

Aceto Boosts Life Sciences with Biotron Buy

US specialty materials manufacturer Aceto has acquired Biotron Laboratories and affiliate Talus Mineral, expanding its nutraceuticals business and strengthening its life sciences footprint. Financial terms were not disclosed.

Based in Salt Lake City, Biotron makes premium specialty minerals, trace elements and other solutions used in nutritional supplements and has proprietary technology for producing mineral chelates. It operates two manufacturing facilities located near its Utah headquarters.

“Biotron is the latest of our recent acquisitions of exceptional life-science specialty manufacturers, and they bring important new capabilities to Aceto,” said CEO Gilles Cotter. “Over four decades they have built a strong reputation in the nutritional supplements industry for their unique mineral chelation process, high-quality trace elements and other specialty ingredients. They are known for their focus on R&D and ability to work with customers on a variety of custom and specialty orders. Biotron is a great addition to our already-substantial nutraceuticals business, with a complementary portfolio of customers.”

This latest deal adds to a string of acquisitions in 2021 and 2020. Aceto announced in January that it had consolidated and integrated the six companies and manufacturing facilities that it acquired in less than 18 months. These included A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem and Syntor Fine Chemicals. Aceto was itself acquired in April 2019 by New York investment group New Mountain Capital.

Author: Elaine Burridge, Freelance Journalist

(c) Aceto
(c) Aceto

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.